Life

Jeanie Buss Is Laughing Through Her Pain

Newater Technology Shares Soar 29%

Shares of Newater Technology Inc. (NEWA) are surging over 25% Monday morning, after the company announced that its shareholders voted in favor of the proposal to authorize and approve (i) the previously announced merger agreement dated September 29, 2020 by and among Crouching Tiger Holding Ltd., Green Forest Holding Ltd., and the Company; (ii) the plan of merger required to be filed with the Registrar of Corporate Affairs of the British Virgin Islands, and (iii) the consummation of the transactions contemplated by the Merger Agreement and the Plan of Merger, including the Merger.

The stock, which has been trading in the range of $3.00 – $5.53 for the past one year, is currently trading at $4.86, up $1.12 or $29.94%, with trading volume skyrocketing over 4.79 million versus an average volume of 85K shares.

WHO warns against mixing and matching Covid-19 vaccines

GENEVA (REUTERS) – The World Health Organisation’s chief scientist on Monday (July 12) advised against people mixing and matching Covid-19 vaccines from different manufacturers, calling it a “dangerous trend” since there was little data available about the health impact.

“It’s a little bit of a dangerous trend here. We are in a data-free, evidence-free zone as far as mix and match,” Soumya Swaminathan told an online briefing.

“It will be a chaotic situation in countries if citizens start deciding when and who will be taking a second, a third and a fourth dose.”

More on this topic

This Is How Many People Have Died From COVID-19 in Each State

Since the first death attributable to COVID-19 was reported in the United States on Feb. 29, 2020, an estimated 600,406 Americans have died — and that number still continues to grow.

Adjusting for population, no state has reported more coronavirus deaths than New Jersey. Since the pandemic began, New Jersey has reported a total of 26,473 deaths — or 297 for every 100,000 people. Per capita deaths attributable to the virus are also high in New York, Massachusetts, Rhode Island, and Arizona. In each of these places, the death rate stands at at least 251 per 100,000 people.

For context, the national COVID-19 death rate stands at 184 deaths for every 100,000 people.

To date, Hawaii has reported the fewest coronavirus deaths on a per capita basis. There have been an estimated 36 COVID-19 deaths across the state for every 100,000 people since the pandemic began.

Though it is not always the case, states with higher than average COVID-19 deaths per capita are often also home to larger high-risk populations. One such group is retirement-age Americans, who are at least 90 times more likely to die from the virus if infected than those in the 18 to 29 age group. Nationwide, 16.5% of the population fall into that age group.

And now, inoculations against the coronavirus are well underway in the United States, which will inevitably contribute to a reduction in the death rate.

All COVID-19 data used in the story is current as of July 7, 2021.

Caribou Biosciences Files For IPO

Caribou Biosciences Inc. Thursday announced that it has filed for an initial public offering to fund ongoing drug studies.

The Berkeley, California-based company plans to list its shares on the Nasdaq under the symbol “CRBU.” BofA Securities, Citigroup, and SVB Leerink are listed as the underwriters.

Caribou reported licensing and collaboration revenue of $12.4 million in full year 2020, compared to $5.8 a year ago. The company reported a loss of $34.3 million in 2020, compared $23.4 million in 2019.

“We expect the net proceeds from this offering, together with our existing cash and cash equivalents, will not be sufficient for us to advance any of our product candidates through regulatory approval, and we will need to raise additional capital to complete the development and potential commercialization of any of our product candidates,” the company said in its S-1 filing.

The company said it will use the proceeds to advance the clinical development of its CB-010 product candidate, including funding the ANTLER phase 1 clinical trial through initial data, fund IND-enabling activities and the potential initiation of clinical studies for CB-011 and CB-012 product candidates. The company will also continue research and development of its iPSC-to-NK platform for solid tumor-targeted cell therapies

The company reported cash and cash equivalents of about $16 million at the end of 2020, down from $41.1 million at the end of 2019.

Since its founding in 2011, the company has raised about $150.1 million in funding venture capitals, healthcare-dedicated funds, and other institutional investors.

Some People Flip Real Estate. I Flip Men.

Give me a fixer-upper and I’ll turn him into someone desirable — for someone else.

By Kelly Sundberg

I am a man flipper. I meet a man, fix him up and flip him to someone else. Unlike people who flip real estate — buying houses, renovating them and selling them for a tidy profit — I see no gain from this arrangement, only loss.

Your Next Lesson: Rosé From the Dark Side

By Eric Asimov

The world seems to have embraced the notion that rosé is meant to wear only the palest shade of pink.

Jeanie Buss Is Laughing Through Her Pain

A series of personal and professional losses have challenged the Los Angeles Lakers’ owner in recent years. So she turned to stand-up comedy.

Credit…Tracy Nguyen for The New York Times

Supported by

By Jon Gold

By the time she got to the microphone, the applause had subsided, and Jeanie Buss was faced with the scariest sound for a stand-up comedian.